The Drug Stock Higher on Asset Sale Rumors

TEVA stock has been on the rebound since November

Managing Editor
Dec 26, 2017 at 9:58 AM
facebook X logo linkedin

Drugmaker Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has had a rocky year, culminating in drastic cuts to its workforce and suspended dividend payments. Today, the stock is generating buzz amid reports that Israel's biggest pharmacy chain, Super-Pharm, is in talks to buy a Teva plant. Below, we take a closer look at TEVA stock.

Super-Pharm will reportedly pay between $17 - $23 million for the Ashdod-based plant, and would continue to employ the plant's 70 workers. The news has sent TEVA stock up 2.8% to trade at $19.26 this morning, on pace for its highest close since mid-September. Since falling to a 17-year low of $10.85 on Nov. 2, TEVA has tacked on 78%.

Despite the equity's solid rebound over the past couple of months, analysts remain pessimistic. Of the 23 brokerage firms covering the drug name, 20 rate TEVA shares a "hold" or worse. However, recent options buyers have been upping the bullish ante. On the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 50-day call/put volume ratio of 1.73 is higher than 87% of all other readings from the past year.



How to collect 1 dividend check every day for LIFE

Did you know you could collect 1 dividend check every day the market is open? You could also do it starting with just $605! For me, I'm collecting 70 dividend checks every quarter…which averages around 1.1 dividend checks every business day. There's no trading behind this... no penny stocks or high-risk investments. All you do is buy and hold and you're set. There's no set up required either. If you start buying the dividend stocks I show you today... you could collect 1 dividend per day starting as early as this week. Click here for all the details.